Periodontal Disease Therapeutics Market by Drug Types (Arestin, Atridox, Doxycycline, Metronidazole, Minocycline, Periochip) and Forecast 2017-2021

Periodontal Disease Therapeutics Market by Drug Types (Arestin, Atridox, Doxycycline, Metronidazole, Minocycline, Periochip) and Forecast 2017-2021

Periodontal diseases are among the most common microbial infections in adults and the prime treatment option for periodontal diseases involves mechanical debridment – scaling and root planing (SRP). Research in recent years in periodontology has seen a shift from surgery towards medicine. Scaling and root planing is sometimes followed by adjunctive therapy such as local delivery antimicrobials, systemic antibiotics, and host modulation, as needed on a case-by-case basis.   Dentists and microbiologists across the globe have embraced the usage of antibiotics as an adjunctive therapy for management of periodontal diseases. The antimicrobials have included metronidazole in an ointment form (Elyzol), chlorhexidine (Periochip) as well as doxycycline either in a fiber form (Actisite), or also in a polymeric delivery system (Atridox). World Health Organization (WHO) estimates about 60% to 90% of the school-age children and vast majority of adults with dental caries as a major public health problem in the highest income countries.

The global periodontal disease therapeutics market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).

The global periodontal disease therapeutics market segmentation is based on drug types (Arestin, Atridox, Doxycycline, Metronidazole, Minocycline, PerioChip).

The global periodontal disease therapeutics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global periodontal disease therapeutics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global periodontal disease therapeutics market and included in this report are 3M, DenMat Holdings LLC, Dexcel Pharma, Galderma SA, Kaken Pharmaceuticals, and Valeant Pharmaceutical.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Periodontal Disease Therapeutics Market

1. Drug Type
1.1. Arestin
1.2. Atridox
1.3. Doxycycline
1.4. Metronidazole
1.5. Minocycline
1.6. PerioChip

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Middle East
2.6. Rest of the World

3. Company Profiles
3.1. 3M
3.2. DenMat Holdings, LLC
3.3. Dexcel
3.4. Galderma S.A.
3.5. Kaken Pharmaceuticals Co., Ltd
3.6. Valeant Pharmaceuticals

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*